scholarly journals Oncolytic herpes simplex virus kills stem-like tumor-initiating colon cancer cells

2016 ◽  
Vol 3 ◽  
pp. 16013 ◽  
Author(s):  
Susanne G Warner ◽  
Dana Haddad ◽  
Joyce Au ◽  
Joshua S Carson ◽  
Michael P O’Leary ◽  
...  
Cells ◽  
2021 ◽  
Vol 10 (6) ◽  
pp. 1541
Author(s):  
Norah Aldrak ◽  
Sarah Alsaab ◽  
Aliyah Algethami ◽  
Deepak Bhere ◽  
Hiroaki Wakimoto ◽  
...  

With the increased worldwide burden of cancer, including aggressive and resistant cancers, oncolytic virotherapy has emerged as a viable therapeutic option. Oncolytic herpes simplex virus (oHSV) can be genetically engineered to target cancer cells while sparing normal cells. This leads to the direct killing of cancer cells and the activation of the host immunity to recognize and attack the tumor. Different variants of oHSV have been developed to optimize its antitumor effects. In this review, we discuss the development of oHSV, its antitumor mechanism of action and the clinical trials that have employed oHSV variants to treat different types of tumor.


2004 ◽  
Vol 10 (9) ◽  
pp. 3225-3232 ◽  
Author(s):  
Stephen F. Stanziale ◽  
Henrik Petrowsky ◽  
Prasad S. Adusumilli ◽  
Leah Ben-Porat ◽  
Mithat Gonen ◽  
...  

Gene Therapy ◽  
2016 ◽  
Vol 23 (5) ◽  
pp. 450-459 ◽  
Author(s):  
H Yang ◽  
T Peng ◽  
J Li ◽  
Y Wang ◽  
W Zhang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document